12-08-2026 17:55 via drugs.com

Deramiocel Can Safely Slow Progression in Advanced Duchenne Muscular Dystrophy

WEDNESDAY, Aug. 12, 2026-- Deramiocel, a heart-derived cellular therapy consisting of human allogeneic cardiosphere-derived cells, can safely slow progression of advanced Duchenne muscular dystrophy (DMD), according to a study published online...
Read more »

Pharmaceutical Industry news



Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay
First Metatarsophalangeal Joint Arthrodesis Eases Painful Hallux Rigidus
Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease
Study IDs Neurobiological Roots of Sensory Over-Responsivity
2005 to 2023 Saw Decrease in DXA Testing for Osteoporosis Screening
Endometriosis Tied to Higher Risk for Developing Type 2 Diabetes
Older Adults Limit Movements With Rising Temperatures
Therapeutic Hypothermia Duration Explored in Comatose OHCA Survivors
Physician Normalization of Symptoms May Lead Patients to Not Seek Treatment
Subclinical Cardiac Dysfunction Linked to Neurodegeneration in APOE-ε4 Carriers
Dexamethasone Eye Drops Can Reduce Progression to ROP Requiring Treatment
AMH Predicts Benefit of Chemo + Endocrine Therapy in Under 55s With Breast Cancer
High Temps, Heat Waves Linked to Poorer Mental Health in Children, Teens
Effect of Preparation Techniques Before Embryo Transfer Appears to Be Limited
Desktop versie